drugset / Trial / NCT02806284

Pneumococci and Hib Vaccination After Neurotrauma or Neurosurgery

NCT02806284

Phase 2 Completed 85 enrolled Uppsala University
Non-randomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to determine wether skull trauma or neurosurgery affect the immune response to two vaccine types.

Timeline

Start
2001-01
Primary completion
2008-01
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator ActHIB Vaccine 0.5 ml Subcutaneous
Comparator Pneumovax 23 Vaccine 0.5 ml Subcutaneous

Indications